Evotec, Jain Foundation Expand Muscular Dystrophy Collaboration | GenomeWeb

NEW YORK (GenomeWeb News) – Evotec and the Jain Foundation today said they have extended and expanded their 2012 research collaboration aimed at dysferlinopathy.

Terms of the expanded deal were not disclosed.

Evotec and Jain started a research project in 2012 to develop a cell-based high-throughput screening assay using dysferlin-deficient cells with the goal of identifying compounds that can improve the well-being of dysferlin-deficient muscle cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.